Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Hatcher

Developmental - Behavioral Pediatrics Greenville, SC Medical Doctor

NPI 1275829236 CMS profile 1140952

200 Patewood Dr Ste A200, Greenville, SC 29615

Open in the dashboard

General payments

$161,215

290 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charles Hatcher of Greenville, SC is reported in the CMS Open Payments database as having received $161,215 across 290 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Developmental - Behavioral Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $28,508 37
2024 General $22,177 31
2023 General $21,869 38
2022 General $36,068 79
2021 General $21,734 48
2020 General $26,051 37
2019 General $4,809 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Hatcher
  • Developmental - Behavioral Pediatrics median
  • Middle half of Developmental - Behavioral Pediatrics
  • National median

In program year 2025, general payments to Charles Hatcher were reported at $28,508. Among 160 Developmental - Behavioral Pediatrics profiles paid that year, the median was $77 and the middle half received between $27 and $211.

Show as a table
Year Charles Hatcher Developmental - Behavioral Pediatrics median Middle half National median
2019 $4,809 $106 $28–$315 $163
2020 $26,051 $55 $19–$181 $114
2021 $21,734 $96 $25–$343 $132
2022 $36,068 $86 $23–$235 $149
2023 $21,869 $71 $25–$348 $160
2024 $22,177 $74 $25–$237 $164
2025 $28,508 $77 $27–$211 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ironshore Pharmaceuticals Inc. $64,358 141 payments
  2. Corium, Inc. $49,621 76 payments
  3. Supernus Pharmaceuticals, Inc. $47,144 67 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $39 3 payments
  5. Adlon Therapeutics L.P. $35 2 payments
  6. Tris Pharma Inc $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $102,140 58 payments
  2. Honoraria $27,500 11 payments
  3. Travel and Lodging $13,926 64 payments
  4. Consulting Fee $12,840 5 payments
  5. Food and Beverage $4,809 152 payments
Products named General payments · program years 2019–2025
  1. JORNAY PM Central Nervous Stimulant ADHD $51,391 99 payments
  2. Azstarys $49,621 76 payments
  3. Qelbree Viloxazine Hydrochloride $47,129 66 payments
  4. JORNAY PM Central Nervous System Stimulant $8,235 27 payments
  5. Jornay PM 20mg capsules (Bottle of 100) $4,733 15 payments
  6. ADHANSIA XR $35 2 payments
  7. Vyvanse Central Nervous System (CNS) $24 2 payments
  8. Quillivant XR $17 1 payment
  9. VYVANSE Neuroscience $15 1 payment
  10. QELBREE Psychology $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

290 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Developmental - Behavioral Pediatrics in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record